Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferriprox vs Desferal for Cardiac Iron in Thalassemia Major
NCT00105495Phase 4Completed
- Sponsor
- ApoPharma Inc.
- Start
- Dec 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of deferiprone in beta thalassemia major, hemosiderosis, sponsored by ApoPharma Inc.. Started Dec 2002; status: completed.
02
Drugs
deferiprone
03
Conditions
beta thalassemia majorhemosiderosis
Beyond the preview
Go deeper on NCT00105495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00105495.